A multicenter, randomized, double-blind comparison of the efficacy and safety of irbesartan and enalapril in adults with mild to moderate essential hypertension, as assessed by ambulatory blood pressure monitoring: The MAPAVEL study
- 31 January 2002
- journal article
- clinical trial
- Published by Elsevier
- Vol. 24 (1) , 126-138
- https://doi.org/10.1016/s0149-2918(02)85010-x
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Dose-Related Efficacy of Irbesartan for HypertensionHypertension, 1998
- The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressureArchives of internal medicine (1960), 1997
- Difference between office and ambulatory blood pressure and response to antihypertensive treatmentJournal Of Hypertension, 1996
- Calculation of trough: peak ratio of antihypertensive treatment from ambulatory blood pressure: methodological aspectsJournal Of Hypertension, 1995
- Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipne ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertensionThe American Journal of Cardiology, 1995
- Blood pressure effects of the angiotensin II receptor blocker, losartanArchives of internal medicine (1960), 1995
- Ambulatory blood pressure monitoring use in hypertension research and clinical practice.Hypertension, 1993
- Angiotensin Converting Enzyme Inhibitors and Moderate HypertensionDrugs, 1990
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987
- Alerting reaction and rise in blood pressure during measurement by physician and nurse.Hypertension, 1987